Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Methoxyflurane | hsa00061 | Fatty acid biosynthesis | 4.83E-02 | 1 | P33121 | ACSL1 | More | | Methoxyflurane | hsa00190 | Oxidative phosphorylation | 3.50E-02 | 2 | Q16718, Q13488 | NDUFA5, TCIRG1 | More | | Methoxyflurane | hsa00380 | Tryptophan metabolism | 4.14E-02 | 1 | Q16613 | AANAT | More | | Methoxyflurane | hsa00500 | Starch and sucrose metabolism | 2.86E-02 | 2 | O43451, P46976 | MGAM, GYG1 | More | | Methoxyflurane | hsa00600 | Sphingolipid metabolism | 3.01E-02 | 2 | Q9BX95, P06280 | SGPP1, GLA | More | | Methoxyflurane | hsa00620 | Pyruvate metabolism | 4.20E-02 | 2 | P40926, P14550 | MDH2, AKR1A1 | More | | Methoxyflurane | hsa00730 | Thiamine metabolism | 1.75E-04 | 3 | Q9Y6K8, P05186, P24666 | AK5, ALPL, ACP1 | More | | Methoxyflurane | hsa00770 | Pantothenate and CoA biosynthesis | 1.78E-02 | 2 | O95498, O95497 | VNN2, VNN1 | More | | Methoxyflurane | hsa01100 | Metabolic pathways | 4.56E-02 | 11 | P15144, P32320, P06280, P24666, P33121, P42330, Q13093, Q9NY28, Q9BX95, P09960, Q16718 | ANPEP, CDA, GLA, ACP1, ACSL1, AKR1C3, PLA2G7, GALNT8, SGPP1, LTA4H, NDUFA5 | More | | Methoxyflurane | hsa01240 | Biosynthesis of cofactors | 3.34E-02 | 3 | P05186, Q9Y6K8, O75911 | ALPL, AK5, DHRS3 | More | | Methoxyflurane | hsa03008 | Ribosome biogenesis in eukaryotes | 4.94E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | | Methoxyflurane | hsa03010 | Ribosome | 3.56E-06 | 14 | P62753, P42677, P32969, P40429, P62917, P46776, Q9H0U6, Q07020, P62910, Q02878, P36578, P05386, P62249, P23396 | RPS6, RPS27, RPL9, RPL13A, RPL8, RPL27A, MRPL18, RPL18, RPL32, RPL6, RPL4, RPLP1, RPS16, RPS3 | More | | Methoxyflurane | hsa03020 | RNA polymerase | 9.86E-07 | 2 | Q9GZM3, P52435 | POLR2J2, POLR2J | More | | Methoxyflurane | hsa03050 | Proteasome | 1.40E-02 | 1 | P55036 | PSMD4 | More | | Methoxyflurane | hsa04024 | cAMP signaling pathway | 1.27E-03 | 7 | P49019, P63092, P22694, P26678, P20020, P61586, P48058 | HCAR3, GNAS, PRKACB, PLN, ATP2B1, RHOA, GRIA4 | More | | Methoxyflurane | hsa04072 | Phospholipase D signaling pathway | 2.75E-02 | 3 | P61586, O14986, P63092 | RHOA, PIP5K1B, GNAS | More | | Methoxyflurane | hsa04120 | Ubiquitin mediated proteolysis | 6.89E-03 | 5 | Q14145, Q13042, Q13191, Q15751, Q7Z6Z7 | KEAP1, CDC16, CBLB, HERC1, HUWE1 | More | | Methoxyflurane | hsa04137 | Mitophagy - animal | 2.52E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | | Methoxyflurane | hsa04145 | Phagosome | 2.75E-02 | 4 | Q15080, P14598, P68371, Q13488 | NCF4, NCF1, TUBB2C, TCIRG1 | More | | Methoxyflurane | hsa04217 | Necroptosis | 1.70E-02 | 5 | P01568, Q13489, P08238, O43633, Q08752 | IFNA21, BIRC3, HSP90AB1, CHMP2A, PPID | More | | Methoxyflurane | hsa04310 | Wnt signaling pathway | 4.17E-03 | 3 | P61586, P19784, P67870 | RHOA, CSNK2A2, CSNK2B | More | | Methoxyflurane | hsa04510 | Focal adhesion | 4.07E-02 | 3 | O14986, P61586, Q16363 | PIP5K1B, RHOA, LAMA4 | More | | Methoxyflurane | hsa04520 | Adherens junction | 1.38E-04 | 3 | P19784, P67870, P61586 | CSNK2A2, CSNK2B, RHOA | More | | Methoxyflurane | hsa04621 | NOD-like receptor signaling pathway | 4.31E-02 | 4 | P01375, P59665, P59666, P12838 | TNF, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Methoxyflurane | hsa04640 | Hematopoietic cell lineage | 4.27E-02 | 4 | P08514, P14778, P01730, P13765 | ITGA2B, IL1R1, CD4, HLA-DOB | More | | Methoxyflurane | hsa04650 | Natural killer cell mediated cytotoxicity | 2.11E-02 | 4 | P17252, O60880, P26717, P26715 | PRKCA, SH2D1A, KLRC2, KLRC1 | More | | Methoxyflurane | hsa04659 | Th17 cell differentiation | 2.73E-02 | 4 | Q16539, P01730, P13765, P14778 | MAPK14, CD4, HLA-DOB, IL1R1 | More | | Methoxyflurane | hsa04713 | Circadian entrainment | 1.84E-03 | 5 | P17252, P62873, P48058, P22694, P63092 | PRKCA, GNB1, GRIA4, PRKACB, GNAS | More | | Methoxyflurane | hsa04714 | Thermogenesis | 3.16E-02 | 3 | P22694, P33121, Q16718 | PRKACB, ACSL1, NDUFA5 | More | | Methoxyflurane | hsa04721 | Synaptic vesicle cycle | 1.14E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Methoxyflurane | hsa04723 | Retrograde endocannabinoid signaling | 1.47E-04 | 6 | P17252, P48169, P62873, P48058, P22694, Q16718 | PRKCA, GABRA4, GNB1, GRIA4, PRKACB, NDUFA5 | More | | Methoxyflurane | hsa04724 | Glutamatergic synapse | 1.06E-03 | 5 | P48058, P63092, P22694, P17252, P62873 | GRIA4, GNAS, PRKACB, PRKCA, GNB1 | More | | Methoxyflurane | hsa04726 | Serotonergic synapse | 1.84E-03 | 5 | P63092, P22694, P17252, P31645, P62873 | GNAS, PRKACB, PRKCA, SLC6A4, GNB1 | More | | Methoxyflurane | hsa04911 | Insulin secretion | 3.01E-02 | 2 | P22694, P17252 | PRKACB, PRKCA | More | | Methoxyflurane | hsa04913 | Ovarian steroidogenesis | 1.28E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Methoxyflurane | hsa04918 | Thyroid hormone synthesis | 3.01E-02 | 2 | P22694, P17252 | PRKACB, PRKCA | More | | Methoxyflurane | hsa04925 | Aldosterone synthesis and secretion | 9.86E-03 | 3 | P17252, P22694, P20020 | PRKCA, PRKACB, ATP2B1 | More | | Methoxyflurane | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Methoxyflurane | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 9.85E-05 | 3 | P20020, P17252, P22694 | ATP2B1, PRKCA, PRKACB | More | | Methoxyflurane | hsa04962 | Vasopressin-regulated water reabsorption | 6.61E-03 | 2 | P22694, Q13561 | PRKACB, DCTN2 | More | | Methoxyflurane | hsa04970 | Salivary secretion | 7.14E-03 | 3 | P22694, P20020, P17252 | PRKACB, ATP2B1, PRKCA | More | | Methoxyflurane | hsa04972 | Pancreatic secretion | 1.29E-04 | 4 | P20020, P17252, P63092, P61586 | ATP2B1, PRKCA, GNAS, RHOA | More | | Methoxyflurane | hsa04976 | Bile secretion | 3.01E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Methoxyflurane | hsa05010 | Alzheimer disease | 7.11E-03 | 9 | O15239, P13073, P18848, O15169, P67870, P05141, P12236, P28070, P43686 | NDUFA1, COX4I1, ATF4, AXIN1, CSNK2B, SLC25A5, SLC25A6, PSMB4, PSMC4 | More | | Methoxyflurane | hsa05012 | Parkinson disease | 2.14E-02 | 7 | O15239, P13073, P05141, P12236, P18848, P28070, P43686 | NDUFA1, COX4I1, SLC25A5, SLC25A6, ATF4, PSMB4, PSMC4 | More | | Methoxyflurane | hsa05016 | Huntington disease | 2.46E-05 | 3 | Q9GZM3, P52435, Q9NYC9 | POLR2J2, POLR2J, DNAH9 | More | | Methoxyflurane | hsa05017 | Spinocerebellar ataxia | 4.66E-02 | 4 | P28070, P43686, P05141, P12236 | PSMB4, PSMC4, SLC25A5, SLC25A6 | More | | Methoxyflurane | hsa05020 | Prion disease | 1.55E-03 | 10 | P46531, O15239, P13073, P18848, P05141, P12236, P28070, P43686, P67870, P51636 | NOTCH1, NDUFA1, COX4I1, ATF4, SLC25A5, SLC25A6, PSMB4, PSMC4, CSNK2B, CAV2 | More | | Methoxyflurane | hsa05022 | Pathways of neurodegeneration - multiple diseases | 5.20E-04 | 15 | P67870, O15239, Q16718, P13073, P18848, Q13561, P48058, P05141, P12236, P17252, P20333, O15169, Q08752, P28070, P43686 | CSNK2B, NDUFA1, NDUFA5, COX4I1, ATF4, DCTN2, GRIA4, SLC25A5, SLC25A6, PRKCA, TNFRSF1B, AXIN1, PPID, PSMB4, PSMC4 | More | | Methoxyflurane | hsa05031 | Amphetamine addiction | 1.69E-02 | 3 | P48058, P22694, P17252 | GRIA4, PRKACB, PRKCA | More | | Methoxyflurane | hsa05032 | Morphine addiction | 9.04E-05 | 5 | P62873, P48169, P78334, P63092, P32298 | GNB1, GABRA4, GABRE, GNAS, GRK4 | More | | Methoxyflurane | hsa05100 | Bacterial invasion of epithelial cells | 4.50E-02 | 1 | Q92529 | SHC3 | More | | Methoxyflurane | hsa05110 | Vibrio cholerae infection | 3.01E-02 | 2 | P17252, P22694 | PRKCA, PRKACB | More | | Methoxyflurane | hsa05142 | Chagas disease | 2.26E-02 | 3 | P01375, P30679, P48023 | TNF, GNA15, FASLG | More | | Methoxyflurane | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | | Methoxyflurane | hsa05150 | Staphylococcus aureus infection | 1.83E-02 | 3 | P59665, P59666, P12838 | DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Methoxyflurane | hsa05163 | Human cytomegalovirus infection | 2.09E-02 | 4 | P62873, P61586, P63092, P61769 | GNB1, RHOA, GNAS, B2M | More | | Methoxyflurane | hsa05171 | Coronavirus disease - COVID-19 | 6.74E-07 | 15 | P23396, P62753, P62249, P42677, P40429, Q9UHA3, P36578, Q02878, P62917, P32969, Q07020, P46776, P62910, P05386, O14786 | RPS3, RPS6, RPS16, RPS27, RPL13A, RSL24D1, RPL4, RPL6, RPL8, RPL9, RPL18, RPL27A, RPL32, RPLP1, NRP1 | More | | Methoxyflurane | hsa05224 | Breast cancer | 3.88E-02 | 3 | P46531, Q9UM47, O15169 | NOTCH1, NOTCH3, AXIN1 | More | | Methoxyflurane | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Methoxyflurane | hsa05332 | Graft-versus-host disease | 3.70E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Methoxyflurane | hsa05340 | Primary immunodeficiency | 1.58E-02 | 3 | P01730, P11912, Q8WV28 | CD4, CD79A, BLNK | More | | Methoxyflurane | hsa05415 | Diabetic cardiomyopathy | 2.75E-02 | 4 | P17252, P14598, Q15080, Q16718 | PRKCA, NCF1, NCF4, NDUFA5 | More | | |